Comparison of midwife-led and consultant-led care of healthy women at low risk of childbirth complications in the Republic of Ireland: a randomised trial
© Begley et al; licensee BioMed Central Ltd. 2011
Received: 25 July 2011
Accepted: 29 October 2011
Published: 29 October 2011
No midwifery-led units existed in Ireland before 2004. The aim of this study was to compare midwife-led (MLU) versus consultant-led (CLU) care for healthy, pregnant women without risk factors for labour and delivery.
An unblinded, pragmatic randomised trial was designed, funded by the Health Service Executive (Dublin North-East). Following ethical approval, all women booking prior to 24 weeks of pregnancy at two maternity hospitals with 1,300-3,200 births annually in Ireland were assessed for trial eligibility.1,653 consenting women were centrally randomised on a 2:1 ratio to MLU or CLU care, (1101:552). 'Intention-to-treat' analysis was used to compare 9 key neonatal and maternal outcomes.
No statistically significant difference was found between MLU and CLU in the seven key outcomes: caesarean birth (163 [14.8%] vs 84 [15.2%]; relative risk (RR) 0.97 [95% CI 0.76 to 1.24]), induction (248 [22.5%] vs 138 [25.0%]; RR 0.90 [0.75 to 1.08]), episiotomy (126 [11.4%] vs 68 [12.3%]; RR 0.93 [0.70 to 1.23]), instrumental birth (139 [12.6%] vs 79 [14.3%]; RR 0.88 [0.68 to 1.14]), Apgar scores < 8 (10 [0.9%] vs 9 [1.6%]; RR 0.56 [0.23 to 1.36]), postpartum haemorrhage (144 [13.1%] vs 75 [13.6%]; RR 0.96 [0.74 to 1.25]); breastfeeding initiation (616 [55.9%] vs 317 [57.4%]; RR 0.97 [0.89 to 1.06]). MLU women were significantly less likely to have continuous electronic fetal monitoring (397 [36.1%] vs 313 [56.7%]; RR 0.64 [0.57 to 0.71]), or augmentation of labour (436 [39.6%] vs 314 [56.9%]; RR 0.50 [0.40 to 0.61]).
Midwife-led care, as practised in this study, is as safe as consultant-led care and is associated with less intervention during labour and delivery.
Trial registration number
Maternity care in Ireland is predominantly hospital-based and consultant-led. In the early 21st century, it is provided free of charge to all women attending the 'public', hospital-based, service. Approximately 50% of women have private insurance that covers, or partially covers, the costs for them to attend for care on a 'semi-private' or 'private' basis. The three types of care differ as follows:
Public: cared for antenatally by a team of doctors led by a consultant, cared for in labour and at birth by a team of qualified and student midwives, under the supervision of obstetricians, cared for in the postnatal period in hospital in a public ward, usually with 5 or more beds, for 2-3 days.
Semi-private: cared for antenatally by a non-consultant qualified obstetrician, cared for in labour and at birth by a team of qualified and student midwives, under the supervision of the obstetrician on call, cared for in the postnatal period in hospital in a semi-private, usually 2-4-bedded ward, for 2-3 days. Not available in all hospitals.
Private: cared for antenatally by a chosen consultant obstetrician, cared for in labour and at birth by a team of qualified and student midwives, under the supervision of the obstetrician or their designated replacement, who will often be present for the birth, cared for in the postnatal period in hospital in a private room for 2-5 days.
Some hospitals provide 'out-reach' antenatal and postnatal care clinics, but there are no national community midwifery services available in the public health system, providing either antenatal or postnatal care. The Public Health Nursing service provides a minimum of one home visit, usually within 2 days of discharge from hospital, and further visits if necessary. Women attend their general practitioner (GP) at six weeks for a check-up of themselves and their baby. A small number of self-employed community midwives care for women having a home birth, (n = 148 births, 0.2% of the total 76,021 births in 2009) .
This hospital-based, consultant-led model of maternity care in Ireland has been described as 'highly medicalised'  typified by the use of various forms of 'active management of labour' (AML) in most of the 20 maternity units in Ireland. AML includes involvement of a consultant obstetrician, one-to-one midwifery care and use of routine artificial rupture of membranes (ARM) and intravenous oxytocin if a woman's cervix is not dilating by one centimetre per hour . It has been suggested that the main beneficial effect of AML may arise from continuous support of a midwife rather than routine use of amniotomy and oxytocin . Certainly, early routine ARM, one facet of AML, has been criticised as "not scientifically justified"  and a Cochrane Review found "no shortening of the length of first stage of labour and a possible increase in caesarean section", concluding "routine amniotomy is not recommended for normally progressing labours or in labours which have become prolonged" . Another Cochrane Review found that AML was associated with a small decrease in caesarean section (CS), but that it was "highly prescriptive and interventional"  and the authors advised further research to determine the acceptability of AML to women .
Other models, including midwife-led care, tend to be less prescriptive and are founded on the principle of childbirth being a normal, physiological yet life-changing event. 'Midwife-led care' is defined as care where midwives are, "in partnership with the woman, the lead professional with responsibility for assessment of her needs, planning her care, referral to other professionals as appropriate, and for ensuring provision of maternity services" . Midwife-led units (MLUs) are seen as an important and necessary development in care  and offer the majority of women a woman-centred, [9, 10] cost-effective,  safe  and satisfying [9, 10, 12, 13] alternative to consultant-led care. The most recent published version of the Cochrane Review comparing midwife-led with other forms of care in pregnancy and childbirth involved 11 trials including 12,276 women. Six studies included women at low risk of complications and five recruited women of high, or mixed, levels of risk. Women who received midwife-led care were less likely to have fetal/neonatal loss before 24 weeks, episiotomy, regional analgesia/anaesthesia, instrumental birth, or antenatal hospitalisation; and were more likely to have no intrapartum analgesia/anaesthesia, spontaneous vaginal birth, to feel in control, to be attended at birth by a known midwife and to initiate breastfeeding. Infants of mothers randomised to midwife-led care had a shorter mean length of neonatal hospital stay. No difference was found in antepartum haemorrhage, mean number of antenatal visits, overall fetal loss and neonatal death, fetal loss or neonatal death ≥ 24 weeks, amniotomy, labour augmentation, mean length of labour, induction of labour, use of opiate analgesia, caesarean section, perineal laceration requiring suturing, intact perineum, postpartum haemorrhage, duration of postnatal hospital stay, low birth weight infant, preterm birth, Apgar scores ≤ 7 at 5 minutes, admission of infant to special care or neonatal intensive care, neonatal convulsions, or maternal postpartum depressions. The review concludes "most women should be offered midwife-led models of care and women should be encouraged to ask for this option" . In Ireland, there were no MLUs before 2004, and few examples of midwife-led care. In 2001, the Kinder Report on women's health services in the North-Eastern region emphasised the need for evidence-based care and recommended that MLUs be established in Cavan and Drogheda . Amid uncertainty as to how far the findings of the Cochrane Review on midwife-led care could be applied to an Irish population, the former North-Eastern Health Board (NEHB) (now the Health Service Executive, Dublin North-East (HSE-DNE)) planned the introduction of 'alongside' midwife-led units within a randomised trial (the "MidU" study). The aim was to compare the effects of midwife-led care (in an MLU) with consultant-led care for healthy women without risk factors for labour and delivery, on rate of interventions, maternal satisfaction, and neonatal and maternal outcomes. In addition, the costs of both types of care were to be measured and compared. Rate of interventions, neonatal and maternal outcomes are presented here; cost-effectiveness and maternal satisfaction will be presented in future papers.
Study setting and participants
Two MLUs were constructed in Our Lady of Lourdes Hospital (OLOL) in Drogheda (3,200 births per year) and Cavan General Hospital (CGH), Cavan (1,300 births per year), both located in large towns (28,000 and 4,000 inhabitants respectively) serving a semi-urban and rural population, of mixed race, with white Irish in the majority. Both units were housed within their parent hospital in re-furbished existing accommodation, close to the main labour ward, and aimed to provide an integrated service using evidence-based guidelines and procedural policies. Twelve staff midwives were employed in OLOL MLU and seven in CGH.
This two group, two-centre, pragmatic randomised trial was conducted between July 2004 and June 2007, with a pilot study for the first seven months, which refined the eligibility criteria and practice guidelines. No changes were made to methods after trial commencement. Recruitment to the main study took place from February 2005 to November 2006, with the last birth in June 2007 when the full sample size had been reached. The null hypothesis stated that "there will be no difference found between midwife-led care and consultant-led care for healthy women without risk factors for labour and delivery as measured by rate of interventions, maternal satisfaction and neonatal and maternal morbidity outcomes".
Trial eligibility - maternal exclusion criteria
• ≥ 40 years of age and ≤16 years age at delivery
• Grand multiparity (> 5)
• Height: < 152 cms (5 feet)
• BMI < 18 or > 29
• Medical History: respiratory, renal, infective, immune, neurological, cardiovascular, gastrointestinal, endocrine, haematological, mental ill-health, muscoskeletal
Current history of drug misuse
Smoking ≥ 20 cigarettes per day
• Latex allergy
• Previous obstetric history
History of preterm birth at < 34 weeks gestation, recurrent miscarriage, moderate to severe pre-eclampsia,intra-uterine growth restriction, previous stillbirth, CS, eclampsia, uterine rupture, placental abruption, PUPP, obstetric cholestasis, 3rd or 4th degree tear, PPH (> 500 mls or symptomatic), manual removal of placenta, shoulder dystocia, midtrimester miscarriage, neonatal death, infant with hypoxic ischaemic encephalopathy
• Previous gynaecological history
Uterine surgery, myomectomy, hysterotomy, cone biopsy (unless subsequent term vaginal delivery), two previous Letz procedures, uterine fibroids, cervical cerclage, infertitlity, uterine anomaly, perineal reconstruction (more than 24 hours post birth)
The Faculty of Health Sciences Research Ethics Committee of Trinity College Dublin and the former NEHB approved the study. An independent Data and Safety Monitoring Board (DSMB) was established and conducted an interim analysis on data on the first 495 women in the main study (33%), with a stopping guideline alpha of 0.001 . The DSMB found insufficient evidence of benefit or harm in either group and recommended the study should continue. The second interim analysis did not take place as the full sample size had already been recruited by the time manual collection of all data on the first 66% of the planned sample size had been completed.
Randomisation and masking
Women were randomised to a MLU or consultant-led unit (CLU) in a two to one ratio (to make cost-effective use of the refurbished MLUs and allocated staff), using an independent telephone randomisation service. Random sequences of block sizes of two, three, four or five were used, stratified by study centre using a separate block randomisation list for each of the two centres, and by random permutations of group allocation within each block. Block sizes were concealed until completion of the trial. Random integers were obtained using a random number generator available in StatsDirect . The enrolling midwife logged demographics, eligibility, consent and contact details, provided this to the randomisation service and was then informed of the allocation (MLU or CLU) and the unique study number.
As there was no access to MLU care except through the study, carers were aware that all women in the MLU were included in MidU. Therefore, identification of women randomised to the CLU group was not masked, as blinding participants allocated to control groups when it is impossible to blind those in experimental groups has been criticised . Ensuring that all women, and their carers, were aware of their trial status should minimise the impact of this on differences in outcomes between the groups.
Women randomised to CLU received standard care: antenatal care provided by obstetricians and, if desired, by the woman's GP, supported by the hospital medical team with assistance from midwives, who did not usually perform assessment; intrapartum care provided by midwives unless complications developed, with consultant overview; and postpartum care (2-3 days in hospital) provided by midwives, overseen by consultants. Women were discharged into the care of Public Health Nurses.
Transfer criteria during pregnancy
• Rhesus disease
• Prolonged pregnancy i.e. > 40+10
• Gestational diabetes
• Clinically suspected small for gestational age baby
• Atypical antibodies
• Pre-term spontaneous rupture of the membranes
• Pre-labour rupture of membranes at term for > 48 hrs
• Known fetal anomaly
• Antepartum haemorrhage
• Gestational Hypertension (≥ 140/90 mmHg)
• Induction of labour
• Multiple pregnancy
• Symptomatic vaginal discharge.
• Maternal request for prenatal screening
• Unbooked pregnancy
• Reduced fetal movements
• Plancental abruption
• Proteinuria ≥ 1+ on repeat specimen at same visit.
• Group B Strep
• Unstable lie
• Suspected thromboembolism
• More than two admissions in ≥ 48 hours at term and not in established labour
• Malpresentation after 37 completed weeks
• Any itchy rash
• Placenta praevia
• Hb < 10 g/dL
• Preterm labour before 37 completed weeks
Intrapartum transfer criteria
• Placental abruption
• Shoulder dystocia
• Abnormal fetal heart rate on auscultation - if prolonged deceleration ≥ 2 mins < 110 bpm is diagnosed, the woman was transferred to the CLU
• Meconium stained liquor
• Pyrexia > 38°C on two occasions at least 1 hour apart
• Request for epidural
• Malpresentation (with exception of mento-anterior)
• Lack of progress in the first stage of labour (absent or slower cervical dilatation than 0.5 cm/hr for primigravidae and 1 cm/hr for multigravidae
• Unbooked and presenting in early labour
• Intrapartum haemorrhage
• Delay in the second stage of labour (active pushing for more than 90 mins primigravidae or 40 mins for multigravidae)
• Retained placenta (> 1 hr)
• Cord presentation/prolapsed
• PPH (> 1000 mls or if symptomatic)
• Fetal demise
• 3rd/4th degree perineal tears
• Absence of liquor
Postnatal transfer criteria
• Postpartum haemorrhage (> 500 mls)
• Signs of deep vein thromboembolism: leg pain or discomfort, (especially in the left leg), swelling, tenderness, increased temperature and oedema, and lower abdominal pain
• Signs of pulmonary thromboembolism: dyspnoea, collapse, chest pain, haemoptysis, faintness, and signs and symptoms associated with DVT
• Pyrexia > 38C on two occasions at least 1 hour apart
• Any other condition that causes concern
• Concerns for psycho-logical wellbeing
Data were collected manually from women's and neonates' charts by research assistants and double-entered into a computerised database, checked and cleaned. Verified data were transferred into SPSS (version 16.0) for analysis.
MidU contained several primary outcomes, reflecting the diversity of opinion about which outcomes are most important in maternity care. The sample size required was 1,539, taking account of the two to one randomisation ratio and based on two-tailed tests. This assumed a criterion for significance (alpha) of 0.05, and sufficient power (at ≥ 0.80) to detect differences of at least 6% between consultant-led care and midwife-led care in MLUs in rates of induction of labour (23% to 17%), episiotomy (31% to 24%) and augmentation of labour (24.4% to 17.9%). Effect sizes for primary outcome measures were informed by the literature and agreed by study site clinicians. This sample size would also, with the same or greater levels of significance and power, detect differences in proportions between CLU and MLU in Apgar score at five minutes of 8-10: (97.2% to 93.2%); initiation of breastfeeding: (40% to 50%); CS: (11.2% to 6.2%); continuous electronic fetal monitoring (EFM): (23% to 16%); instrumental birth: (10.4% to 5.4%); postpartum haemorrhage (> 500 mls): (8% to 4%); and mean umbilical cord pH: mean difference of 0.02 with a common within-group standard deviation of 0.096. Secondary outcomes were also identified and listed in the study protocol.
Data analysis was by 'intention-to-treat'. Study results are reported as a summary of the outcome in each group (with denominators being the number of women randomised), or the mean and standard deviation of measurements. Summary statistics using risk ratios (relative risks (RR)) for dichotomous outcomes, and mean difference for continuous outcomes are reported, with 95% confidence intervals (CI) .
The protocol for the MidU study was registered with the International Standard Randomised Controlled Trial Number Register (ISRCTN14973283, http://www.controlled-trials.com/ISRCTN14973283) and no important changes were made to the methods after the trial started. Results are reported in accordance with the latest CONSORT statement [19–21].
Mean age years (SD)
Parity 0 (%)
Parity > 0 (%)
Married, not separated (%)
Mean weight Kgs (SD)
Mean height metres (SD)
RR 0.97, 95% CI 0.76, 1.24
Induction of labour
RR 0.90, 95% CI 0.75, 1.08
RR 0.93, 95% CI 0.70, 1.23
RR 0.88, 95% CI 0.68, 1.14
Apgar scores less than 8
RR 0.56, 95% CI 0.23, 1.36)
Postpartum haemorrhage (PPH)
RR 0.96, 95% CI 0.74, 1.25
Initiation of breastfeeding
RR 0.97, 95% CI 0.89, 1.06
RR 0.64, 95% CI 0.57, 0.71
RR 0.50, 95% CI 0.40, 0.61
MLU women were significantly less likely to receive continuous EFM (available only in CLU) (397 [36.1%] vs 313 [56.7%]; RR 0.64, 95% CI 0.57, 0.71), or have labour augmented by amniotomy or with oxytocin (436 [39.6%] vs 314 [56.9%]; RR 0.50, 95% CI 0.40, 0.61) (Table 6). Cord blood pH measurement could not be undertaken without cord-clamping, which was not part of the protocol of care in the MLUs (because cord-clamping would have excluded expectant third stage management).
MD -0.51, 95% CI -0.68, -0.34
MD -1.01 95% CI -1.39, -0.63)
RR 1.07, 95% CI0.95, 1.20
RR 1.13, 95% CI 0.93, 1.38
Fetal loss prior to 24 weeks
RR 1.70, 95% CI 0.63, 4.60
RR 0.76, 95% CI 0.62, 0.92
Included transcutaneous electrical nerve stimulation (TENS)
RR 1.33, 95% CI 1.02, 1.74
RR 7.16, 95% CI 4.49, 11.42
One or two caregivers
RR 1.58, 95% CI 1.29, 1.95
Length of labour (hrs)
MD 0.53, 95% CI 0.25, 0.81)
RR 1.18, 95% CI 1.08, 1.29
Upright positions for birthing
RR 2.73, 95% CI 2.09, 3.58
Physiological management of third stage of labour
RR 68.69, 95% CI 9.63, 489.80
Spontaneous vaginal birth
RR 1.03, 95% CI 0.96, 1.10
RR 0.96, 95% CI 0.85, 1.09
Estimated blood loss mls
MD 6.17, 95% CI -32.12, 44.46
Postnatal stay of 1 day or less
RR 1.62, 95% CI 1.22, 2.14
Paediatric care required
RR 0.98, 95% CI 0.82, 1.15
RR 1.03, 95% CI 0.78, 1.37
RR 0.96, 95% CI 0.48, 1.92
Admission to special care baby unit
RR 1.07, 95% CI 0.80, 1.43
Women randomised to MLU had significantly fewer mean ultrasound examinations (1.98 (SD 1.37) vs 2.49 (SD 1.75), mean difference (MD) -0.51, 95% CI -0.68, -0.34), and antenatal cardiotocographs (2.38 (SD 3.6) vs 3.39 (SD 3.77), MD -1.01 95% CI -1.39, -0.63). Significantly fewer MLU women chose to have epidurals (for which they had to transfer to CLU) (202 [18.3%] vs 134 [24.3%]; RR 0.76, 95% CI 0.62, 0.92). Alternative methods of pain relief included transcutaneous electrical nerve stimulation (TENS) (64 [16%] vs 170 [12%]; RR 1.33, 95% CI 1.02, 1.74 and hydrotherapy (birthing pool in MLU, bath in CLU) (257 [23.3%] vs CLU 18 [3.3%]; RR 7.16, 95% CI 4.49, 11.42). Twenty-seven percent of MLU women (n = 297) had only one or two caregivers in labour, compared with 17% (n = 94) in CLU (RR 1.58, 95% CI 1.29, 1.95). MLU women had a longer mean length of labour (4.6 hours (SD 3.27) vs 4.0.hours (SD 2.41); mean difference 0.53, 95% CI 0.25, 0.81) (Table 7). MLU women more frequently used spontaneous pushing (726 [65.9%] vs 308 [55.8%]; RR 1.18, 95% CI 1.08, 1.29), upright positions for birthing (300 [27.2%] vs 55 [10.0%]; RR 2.73, 95% CI 2.09, 3.58), physiological management of third stage of labour (137 [12.4%] vs 1 [0.2%]; RR 68.69, 95% CI 9.63, 489.80). More MLU women stayed only one postnatal day or less (184 [16.7%] vs 57 [10.3%]; RR 1.62, 95% CI 1.22, 2.14) (Table 7).
Neonatal outcomes showed no statistically significant difference between MLU and CLU in paediatric care required (292 [26.5%] vs 150 [27.2%]; RR 0.98, 95% CI 0.82, 1.15); facial oxygen (130 [11.8%] vs 63 [11.4%]; RR 1.03, 95% CI 0.78, 1.37); bag-and-mask resuscitation (23 [2.1%] vs 12 [2.2%]; RR 0.96, 95% CI 0.48, 1.92); admission to special care baby unit (SCBU) (128 [11.6%] vs 60 [10.9%]; RR 1.07, 95% CI 0.80, 1.43) (Table 7). There were two early neonatal deaths in MLU (0.18%), two (0.36%) in CLU, and one (0.1%) fetal loss at > 24 weeks in MLU. Perinatal mortality rates in MLU and CLU were 2.76 and 3.66 per 1,000 live and still-births. There were no maternal deaths. Other secondary and sub-group analyses are in the full study report . The satisfaction survey and economic analysis will be reported separately.
The trial's main limitation is the lack of blinding of participants and carers as all women attending MLU were known to be in the study intervention group. Those allocated to CLU care were not masked either, as the blinding of participants allocated to control groups in such situations has been criticised . Unavoidable potential bias thus exists for both randomised groups. Assessors for certain outcomes, such as laboratory tests, were blinded to study group. The outcome 'blood loss' was estimated, as per hospital protocols, and amounts are thus imprecise in both groups.
The focus of this study was on the relative effects of midwife-led care provided in the setting of an alongside MLU. As such, this study combines elements of midwife-led care including continuity of care in pregnancy and birth with settings for birth i.e. the MLU. We acknowledge that not all midwife-led models of care will take place in an alongside MLU nor, indeed, in a home-like environment . Further, not all alternative settings for birth will provide midwife-led care . Differentiating the effects of midwife-led care from the setting of that care is not possible within this study, a limitation that is not unique to our study. The potential confounding effect of practice settings such as MLU on the outcomes of midwife-led care is complex as are the interrelationships between philosophy and continuity of care .
In this study, the percentage of women transferring from MLU to CLU care in the antenatal period, in particular, is higher (at 45%) than quoted rates of 24% in some UK centres . The permanent transfer rates of 13% intrapartum and 0.5% postnatally are approximately the same as the 12-15% and up to 8% reported in the UK . Some of the reasons for permanent transfer such as induction of labour and premature labour should not automatically preclude women from being transferred back to MLU care in the postnatal period, if appropriate. Quality reviews and audits of reasons for transfer would assist in reducing these high rates to more normal levels.
The strength of this trial lies in its size, and in its serendipitous conduct prior to the introduction of MLUs, in Ireland, due to the enlightened vision of the (then) North-Eastern Health Board in planning service innovation formally within the framework of a clinical trial. The MidU study is likely to have good external validity, as the setting of the trial is similar to many birthing units in the UK and other countries. Identifying eligible women was done using clinical criteria of 'low risk' similar to, or sometimes more stringent than, those used in many other centres, and 43% of women met those criteria. As 50% of these women also agreed to join the trial, there is a large enough proportion to warrant introducing a new scheme. Furthermore, the MLU intervention described in the trial protocol and implemented in the trial itself for women allocated to the MLU arm can be regarded as standard practice for MLU care in the two study sites, since the relevant procedures were established in the context of the MidU trial. Similarly, the control intervention in MidU reflects standard practice for women receiving CLU care in these two sites.
We calculated the sample size for the MidU trial using estimates for induction of labour, episiotomy and augmentation of labour. We also calculated the effect sizes that this would allow us to detect for other important outcomes and included this information in the protocol for the trial and within this report. We thus had several "primary outcomes" because complex interventions such as models of maternity care involve a variety of people including pregnant women, practitioners, policy makers and the public, all of whom are likely to be interested in the results of a randomised trial. These people can have different priorities when assessing the evidence from a trial such as MidU, and it is unclear whose priorities should be given prominence by choosing a single primary outcome. This diversity of opinion was confirmed in many discussions before, during and after the trial and, so, by explicitly selecting several primary outcomes, we committed ourselves to making the findings for each of these available in the report of the study, including all adverse outcomes, as we have done here. In this way, we leave it to readers to use their own priorities to decide whether any single outcome, or combination of outcomes, is the most important for their interpretation of the findings of MidU.
The results reported here show that midwife-led care, as practised in this study in an 'alongside' MLU, is as safe as consultant-led care and is associated with less intervention. Women cared for in the MLUs were significantly less likely to receive continuous EFM, or have their labour augmented, with no statistically significant difference in adverse neonatal or maternal outcomes such as low Apgar scores, resuscitation, admission to SCBU, CS, instrumental birth or PPH. Other intervention rates, such as episiotomy and induction of labour, were similar in both groups.
The lower rate of EFM in the MLUs should be seen in the context of knowledge that the predictive ability of abnormal fetal heart rate patterns to identify fetal metabolic acidosis and hypoxic-ischemic encephalopathy is low . The Cochrane Review of continuous cardiotocography (CTG) during labour found that, in 12 trials with more than 37,000 women, continuous EFM was associated with a significant increase in CS rates and instrumental birth with no difference shown in cerebral palsy or neonatal mortality. EFM was, however, associated with a reduction in neonatal seizures . Despite the significantly lower use of EFM in women randomised to MLU, there was no difference in the CS rates between the groups. Although counter-intuitive, this finding is consistent with the Cochrane Review on midwife-led care . The lower rate of instrumental vaginal births is consistent with the Cochrane Reviews on both continuous CTG  and midwife-led care .
Augmentation of labour, through 'active management,' was introduced in the 1970s in Ireland to prevent prolonged primigravid labours and save 60% on birth costs . A review comparing routine care with early amniotomy and oxytocin for delay in first stage spontaneous labour found that early intervention was associated with a modest reduction in CS rates but there was insufficient evidence on maternal or neonatal outcomes . The higher augmentation rates for women in CLU in this study are not associated with a reduction in complications in the fetus or neonate, or with a decrease in operative or instrumental birth rates, and are therefore unnecessary in low-risk women.
Recent editorial commentary in the Lancet recommended that trialists should set their findings in the context of an up-to-date systematic review, in order to acknowledge the place of their results in the world literature . In line with this recommendation, a comparison of MidU primary and some secondary outcome results with the Cochrane Review of midwife-led versus consultant-led care was conducted,  and shows some differences but many similarities. Only those results where the addition of the MidU data did not lead to substantial increases in the I2 statistic for heterogeneity (greater than I2 = 75%) have been presented.
The addition of the MidU findings strengthens the findings of the review, increasing the statistical power of the meta-analyses and changing some results from statistically significant to non-significant for the secondary outcomes of 'antenatal hospitalisation' (RR 0.90 95% CI 0.81, 0.99 I2 = 32% without MidU, to RR 0.96 95% CI 0.89, 1.03 I2 = 49% with MidU); and 'fetal/neonatal loss before 24 weeks' (RR 0.79 95% CI 0.65, 0.97 I2 = 0% without MidU, to RR 0.82, 95% CI 0.67, 1.00 I2 = 0% with MidU). The addition of MidU also changes the results of the meta-analyses from non-significant to significant in favour of MLU for the outcome 'amniotomy' (RR 0.88 95% CI 0.75, 1.04 I2 = 41% without MidU; to RR 0.80 95% CI 0.66, 0.97 I2 = 74% with MidU), and in favour of CLU for the outcome 'shorter mean length of labour' (mean difference 0.27 95% CI -0.18, 0.72 I2 = 0% without MidU to mean difference 0.46 95% CI 0.22, 0.70 I2 = 0% with MidU). As in MidU, four studies included in the Cochrane Review  found significant reduced rates of augmentation of labour in MLUs, but the remaining six showed no difference. Overall, meta-analyses do not show a significant difference in this outcome, with or without the addition of MidU data . In the MidU study, induction of labour, PPH and low Apgar scores were not different between the two groups, in accord with the Cochrane Review findings. The MidU study, in common with eight others in the review, showed a reduction in instrumental birth in MLUs, which was not statistically significant. The increased power available in the Cochrane meta-analysis, before and after addition of the MidU data, continues to show a significant decrease in instrumental birth rates in favour of MLUs . Similarly, the MidU study, in common with five others in the Cochrane Review, showed a non-significant reduction in episiotomies for MLU women. One other study in the review showed no difference, but five showed a statistically significant difference in favour of MLU care. The increased power available in the Cochrane meta-analysis, before and after addition of the MidU data, shows a significant difference in episiotomy rate in favour of MLUs . Consistent with MidU, the Cochrane Review finds no significant difference in 'fetal loss/neonatal death equal to/after 24 weeks' before and after the addition of MidU data.
In summary, MidU adds to the totality of evidence available by substantiating and adding to the results of previous research. The similarity between MidU and other international studies in the Cochrane Review shows that our findings have good generalisability. Further research is necessary into ways of decreasing non-essential interventions for healthy women in normal labour, to increase the normal birth rate for healthy women at low risk to complications.
This study supports the recommendation of the Cochrane Review  that midwife-led care should be offered to most women. The implications of this for maternity care are profound, particularly in Ireland where at least 40% of women are eligible, and suitable, for midwife-led care (using strict criteria), which has been shown to be as safe as consultant-led care but associated with less intervention when provided in an 'alongside' MLU. Therefore, it is reasonable to suggest that midwife-led care should be the norm for low-risk women. Consideration should be given to the establishment of MLUs where they are not the norm, using the model of midwife-led care practised in this study, with similar resources.
List of abbreviations used
Active management of labour
Artificial rupture of membranes
North-Eastern Health Board
Health Service Executive, Dublin North-East
Our Lady of Lourdes Hospital
Cavan General Hospital
Data and Safety Monitoring Board
Statistical package for the Social Sciences
Electronic fetal monitoring
Transcutaneous electrical nerve stimulation
Pruritic urticarial papules and plaques
Acknowledgements and funding
We are grateful first and foremost to the women in the Health Service Executive-Dublin North-East (HSE-DNE) who agreed to join the MidU study. We thank all the staff who assisted us with access for the study and who gave their support, particularly all the midwives, and the obstetricians who collaborated so closely in providing back-up services for the MLUs. The support of the neonatologists, public health nurses and general practitioners involved is gratefully acknowledged. Special thanks are extended to the group of midwife data collectors. The members of the Data Safety and Monitoring Board are also thanked for their contribution. The study team would like to thank the Maternity Services Taskforce of the HSE-DNE for their constant support of the study over the past seven years.
Funding to support the introduction of the computerised Maternity Information System in the two study sites was gratefully received from the Health Research Board [Health Information Infrastructure Grant-EQ/2004/3]. Our thanks also go to the former North-Eastern Health Board, now the Health Service Executive - Dublin North-East, who provided funding for the study. The HSE-DNE had no role in study design, data collection, analysis, interpretation or report-writing or in the decision to submit the article for publication. The researchers are entirely independent from the funders.
Details of ethics approval
The North Eastern Health Board had no Ethics Committee at the time of planning of the study, and stated on 17th February 2003 that ethics approval from the School of Nursing and Midwifery would be sufficient. The School of Nursing and Midwifery Research Ethics Committee, Trinity College Dublin, approved the study on 28th March 2003. A Faculty of Health Sciences Research Ethics Committee was set up in Trinity College Dublin in 2005 and approved the study on 21st March 2005. An Ethics Committee was set up in the former NEHB in 2004 and confirmed approval of the study on 22nd April 2004.
- Economic and Social Research Institute: Perinatal Statistics Report 2009. 2011, Dublin: Economic and Social Research InstituteGoogle Scholar
- Wagner M: Fish can't see water: the need to humanize birth. Int J Gynaecol Obstet. 2001, 75: S25-37.View ArticlePubMedGoogle Scholar
- Thornton JG, Lilford RJ: Active management of labour: current knowledge and research issues. BMJ. 1994, 309: 366-9. 10.1136/bmj.309.6951.366.View ArticlePubMedPubMed CentralGoogle Scholar
- Wagner M: Pursuing the birth machine: the search for appropriate birth technology. 1994, Sevenoaks, Kent: ACE GraphicsGoogle Scholar
- Smyth RMD, Alldred SK, Markham C: Amniotomy for shortening spontaneous labour. Cochrane Database Syst Rev. 2007, CD006167-4
- Brown HC, Paranjothy S, Dowswell T, Thomas J: Package of care for active management in labour for reducing caesarean section rates in low-risk women. Cochrane Database Syst Rev. 2008, CD004907-4
- Hatem M, Sandall J, Devane D, Soltani H, Gates S: Midwife-led versus other models of care for childbearing women. Cochrane Database of Systematic Reviews. 2008, CD004667-4
- WHO: Care in Normal Birth: a practical guide. 1996, Geneva: World Health OrganisationGoogle Scholar
- Spitzer M: Birth centres: economy, safety and empowerment. Journal of Nurse-Midwifery. 1995, 40 (4): 371-5. 10.1016/0091-2182(95)00033-G.View ArticlePubMedGoogle Scholar
- Saunders D, Boulton M, Chapple J, Ratcliffe J, Levitan J: Evaluation of the Edgware Birth Centre. 2000, Middlesex: North Thames Perinatal Public HealthGoogle Scholar
- Olsen O, Jewell D: Home versus hospital birth. Cochrane Database of Systematic Reviews. 2006, CD000352-2
- Royal College of Midwives: Vision 2000 Policy Document. 2000, London: Royal College of MidwivesGoogle Scholar
- Royal College of Midwives: Birth centres: position statement. 2007, London: Royal College of Midwives, (accessed 20th July 2011), [http://www.nnt.nhs.uk/maternity/docs/RCM%20Position%20Statement%202004.pdf]Google Scholar
- Kinder P: Report of the Maternity Services Review Group. 2001, Kells: North Eastern Health BoardGoogle Scholar
- Schulz KF, Grimes DA: Multiplicity in randomised trials II: subgroup and interim analyses. Lancet. 2005, 365: 1657-61. 10.1016/S0140-6736(05)66516-6.View ArticlePubMedGoogle Scholar
- StatsDirect: StatsDirect Statistical Software. 2003, StatsDirect: CheshireGoogle Scholar
- Grant JM: Midwife-managed care (Letter). Lancet. 1996, 348 (9035): 1172-View ArticlePubMedGoogle Scholar
- Altman DG: Practical Statistics for Medical Research. 1990, London: Chapman and Hall/CRCGoogle Scholar
- Schulz KF, Altman DG, Moher D, for the CONSORT Group: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Medicine. 2010, 8: 18-10.1186/1741-7015-8-18.View ArticlePubMedPubMed CentralGoogle Scholar
- Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, for the CONSORT Group, et al: CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trial. BMJ. 2010, 340: c869-10.1136/bmj.c869.View ArticlePubMedPubMed CentralGoogle Scholar
- Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, for the CONSORT and Pragmatic Trials in Healthcare (Practihc) group, et al: Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008, 337: a2390-10.1136/bmj.a2390.View ArticlePubMedPubMed CentralGoogle Scholar
- Begley C, Devane D, Clarke M: An evaluation of midwife-led care in the Health Service Executive North Eastern Area: the report of the MidU study. Unpublished report. 2009, Dublin: Health Service Executive, (accessed 20th July 2011), [http://www.hse.ie/eng/services/Publications/services/Hospitals/midwifery%20north%20east.pdf]Google Scholar
- Hodnett ED, Downe S, Walsh D, Weston J: Alternative versus conventional institutional settings for birth. Cochrane Database of Systematic Reviews. 2010, CD000012-9
- Larma JD, Silva AM, Holcroft CJ, Thompson RE, Donohue PK, Graham EM: Intrapartum electronic fetal heart rate monitoring and the identification of metabolic acidosis and hypoxic-ischemic encephalopathy. Am J Obstet Gynecol. 2007, 197 (3): 301.e1-8. 10.1016/j.ajog.2007.06.053.View ArticleGoogle Scholar
- Alfirevic Z, Devane D, Gyte GML: Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2006, CD006066-3
- O'Driscoll K: Impact of active management on delivery unit practice. Proceedings of the Royal Society of Medicine. 1972, 65 (August): 697-8.PubMedPubMed CentralGoogle Scholar
- Wei S, Wo BL, Xu H, Luo Z-C, Roy C, Fraser WD: Early amniotomy and early oxytocin for prevention of, or therapy for, delay in first stage spontaneous labour compared with routine care. Cochrane Database Syst Rev. 2009, CD006794-2
- Clark S, Horton R: Putting research into context--revisited. The Lancet. 2010, 376 (9734): 10-1. 10.1016/S0140-6736(10)61001-X. [http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61001-X/fulltext]View ArticleGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2393/11/85/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.